Immunoparesis status in immunoglobulin light chain amyloidosis at diagnosis affects response and survival by regimen type
Eli Muchtar(Mayo Clinic), Morie A. Gertz(Medical University of South Carolina), Rajshekhar Chakraborty(Columbia University Irving Medical Center), Francis K. Buadi, JA Lust(Mayo Clinic in Arizona), Nelson Leung(WinnMed), Robert A. Kyle(Mayo Clinic), Shaji Kumar(Mayo Clinic), Ronald S. Go(Mayo Clinic), Prashant Kapoor, Stephen J. Russell(University of Minnesota Rochester), Steven R. Zeldenrust, S. Vincent Rajkumar(WinnMed), Martha Q. Lacy(Mayo Clinic), Yi Lin, Angela Dispenzieri(Mayo Clinic), S. R. Hayman(Mayo Clinic), David Dingli
Cited by 10
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2019|1.7k